L-Arginine | Prediabetes Supplement Research

l-arginine benefits researchL-Arginine prediabetes supplement science abstracts related to diabetes and pre-diabetes metabolic syndrome health.

Go to PubMed and copy the title in the search field.

2012

Effects of L: –arginine supplementation on blood flow, oxidative stress status and exercise responses in young adults with uncomplicated type I diabetes.

A sportomics strategy to analyze the ability of arginine to modulate both ammonia and lymphocyte levels in blood after high-intensity exercise.

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects.

Regulatory roles for L-arginine in reducing white adipose tissue.

Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial.

The effect of oral L-arginine supplementation on fasting glucose, HbA1c, nitric oxide and total antioxidant status in diabetic patients with atherosclerotic peripheral arterial disease of lower extremities.

Acute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained men.

Amino acid and vitamin supplementation improved health conditions in elderly participants.

Watermelon extract supplementation reduces ankle blood pressure and carotid augmentation index in obese adults with prehypertension or hypertension.

The effect of different doses of an arginine-containing supplement on the healing of pressure ulcers.

Tetrahydrobiopterin, –arginine and vitamin C act synergistically to decrease oxidative stress, increase nitric oxide and improve blood flow after induction of hindlimb ischemia in the rat.

The effect of nitric-oxide-related supplements on human performance.

Acute l-arginine supplementation increases muscle blood volume but not strength performance.

2009

Amino acids: metabolism, functions, and nutrition.

Arginine metabolism and nutrition in growth, health and disease.

Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials.

Oral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase.

Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.

L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.

Leptin-induced endothelial dysfunction in obesity.

Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injury.

Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis.

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.

Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.

The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.

L-arginine attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells.

Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide.

Vascular insulin-like growth factor-I resistance and diet-induced obesity.

Share Button